217330 — Cytogen Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Annual cashflow statement for Cytogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4,141	-4,889	-10,871	-18,771	-15,770
Depreciation
Amortisation
Non-Cash Items	109	-717	4,255	10,950	6,553
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-313	97.3	272	129	-289
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-3,368	-4,466	-5,230	-6,379	-7,594
Capital Expenditures	-667	-450	-1,997	-745	-2,622
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	12,351	-3,640	-3,588	-5,909	2,886
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	11,684	-4,090	-5,585	-6,654	263
Financing Cash Flow Items	42.2	59.7	43.3	14.2	-2.26
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-343	9,643	30,027	-1,039	46,236
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,973	1,010	19,212	-14,410	38,960